earnings
confidence high
sentiment positive
materiality 0.80
Charles River Q4 rev $905.1M (+14.4%); reaffirms 2022 guidance with non-GAAP EPS $11.50-$11.75
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
2021-FY EPS reported
$7.60
revenue$3,540,160,000
- Q4 GAAP EPS $2.67 vs $2.81 prior year (-5%); non-GAAP EPS $2.49 vs $2.39 (+4.2%).
- Full-year 2021 revenue $3.54B (+21.1%); organic growth 15.1%; non-GAAP EPS $10.32 (+26.9%).
- RMS segment organic growth 13.3%; DSA organic growth 6.7%; Manufacturing organic growth 21.2%.
- 2022 guidance: organic revenue growth 12.5-14.5%; non-GAAP EPS $11.50-$11.75; free cash flow ~$450M.
- GAAP net income Q4 $137.6M vs $143.2M; full-year $391M vs $364.3M.